Table 2 Characteristics of components of metabolic syndrome and trends among three groups
Non-MetS (A) (95% CI) | Pre-MetS (B) (95% CI) | MetS (C) (95% CI) | Post hoc | SSb | P for trendb | |
|---|---|---|---|---|---|---|
(n = 55) | (n = 57) | (n = 56) | ||||
Abdominal obesity | ||||||
WC, cm | 93.0 ± 8.4 (90.7,95.3) | 101.1 ± 8.9 (98.8,103.5) | 101.5 ± 7.0 (99.7,103.4) | A < B, C | 5.04 | < 0.01 |
%Abdominal obesity | 80.0 | 100.0 | 100.0 | |||
Dyslipidemia | ||||||
TG, mg·dL-1 | 90.8 ± 38.7 (80.4,101.3) | 137.5 ± 96.9 (111.7,163.2) | 247.5 ± 166.6 (202.9,292.1) | A, B < C | 8.17 | < 0.01 |
HDLC, mg·dL-1 | 56.3 ± 9.2 (53.8,58.8) | 48.8 ± 10.9 (45.9,51.8) | 47.3 ± 10.7 (44.5,50.2) | A > B, C | -4.44 | < 0.01 |
%Dyslipidemia | 1.8 | 31.6 | 85.7 | |||
Hypertension | ||||||
SBP, mmHg | 116.8 ± 9.2 (114.3,119.3) | 127.0 ± 13.6 (123.4,130.6) | 135.6 ± 12.1 (132.4,138.9) | A < B < C | 7.34 | < 0.01 |
DBP, mmHg | 77.1 ± 6.9 (75.2,78.9) | 86.6 ± 9.2 (84.1,89.0) | 93.5 ± 8.3 (91.2,95.6) | A < B < C | 8.68 | < 0.01 |
%Hypertension | 9.1 | 63.2 | 98.2 | |||
Hyperglycemia | ||||||
FPG, mg/dL | 90.7 ± 6.7 (88.9,92.5) | 94.5 ± 9.0 (92.1,96.9) | 114.1 ± 37.5 (104.1,124.2) | A, B < C | 6.13 | < 0.01 |
%Hyperglycemia | 0.0 | 3.5 | 42.6 | |||